A Single Centre, Pilot Trial of YF476 in Patients With Chronic Atrophic Gastritis, Hypergastrinaemia and Type I Gastric Carcinoids
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Visual assessment of the number of gastric carcinoids.
Malcolm Boyce, BSc FRCP FFPM
Trio Medicines Ltd.
United Kingdom: Medicines and Healthcare Products Regulatory Agency